skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Motzer, Robert ; Alekseev, Boris ; Rha, Sun-Young ; Porta, Camillo ; Eto, Masatoshi ; Powles, Thomas ; Grünwald, Viktor ; Hutson, Thomas E ; Kopyltsov, Evgeny ; Méndez-Vidal, María J ; Kozlov, Vadim ; Alyasova, Anna ; Hong, Sung-Hoo ; Kapoor, Anil ; Alonso Gordoa, Teresa ; Merchan, Jaime R ; Winquist, Eric ; Maroto, Pablo ; Goh, Jeffrey C ; Kim, Miso ; Gurney, Howard ; Patel, Vijay ; Peer, Avivit ; Procopio, Giuseppe ; Takagi, Toshio ; Melichar, Bohuslav ; Rolland, Frederic ; De Giorgi, Ugo ; Wong, Shirley ; Bedke, Jens ; Schmidinger, Manuela ; Dutcus, Corina E ; Smith, Alan D ; Dutta, Lea ; Mody, Kalgi ; Perini, Rodolfo F ; Xing, Dongyuan ; Choueiri, Toni K

The New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Mirza, Mansoor R. ; Chase, Dana M. ; Slomovitz, Brian M. ; dePont Christensen, René ; Novák, Zoltán ; Black, Destin ; Gilbert, Lucy ; Sharma, Sudarshan ; Valabrega, Giorgio ; Landrum, Lisa M. ; Hanker, Lars C. ; Stuckey, Ashley ; Boere, Ingrid ; Gold, Michael A. ; Auranen, Annika ; Pothuri, Bhavana ; Cibula, David ; McCourt, Carolyn ; Raspagliesi, Francesco ; Shahin, Mark S. ; Gill, Sarah E. ; Monk, Bradley J. ; Buscema, Joseph ; Herzog, Thomas J. ; Copeland, Larry J. ; Tian, Min ; He, Zangdong ; Stevens, Shadi ; Zografos, Eleftherios ; Coleman, Robert L. ; Powell, Matthew A.

The New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

Melisi, Davide ; Garcia-Carbonero, Rocio ; Macarulla, Teresa ; Pezet, Denis ; Deplanque, Gael ; Fuchs, Martin ; Trojan, Jorg ; Oettle, Helmut ; Kozloff, Mark ; Cleverly, Ann ; Smith, Claire ; Estrem, Shawn T ; Gueorguieva, Ivelina ; Lahn, Michael M F ; Blunt, Al ; Benhadji, Karim A ; Tabernero, Josep

British journal of cancer, 2018-11, Vol.119 (10), p.1208-1214 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Rosiñol, Laura ; Oriol, Albert ; Teruel, Ana Isabel ; Hernández, Dolores ; López-Jiménez, Javier ; de la Rubia, Javier ; Granell, Miquel ; Besalduch, Joan ; Palomera, Luis ; González, Yolanda ; Etxebeste, Mª Asunción ; Díaz-Mediavilla, Joaquín ; Hernández, Miguel T. ; de Arriba, Felipe ; Gutiérrez, Norma C. ; Martín-Ramos, Mª Luisa ; Cibeira, Mª Teresa ; Mateos, Mª Victoria ; Martínez, Joaquín ; Alegre, Adrián ; Lahuerta, Juan José ; San Miguel, Jesús ; Bladé, Joan

Blood, 2012-08, Vol.120 (8), p.1589-1596 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

du Bois, Andreas, Prof ; Kristensen, Gunnar, Prof ; Ray-Coquard, Isabelle, Prof ; Reuss, Alexander, MSc ; Pignata, Sandro, MD ; Colombo, Nicoletta, Prof ; Denison, Ursula, MD ; Vergote, Ignace, Prof ; del Campo, Jose M, MD ; Ottevanger, Petronella, PhD ; Heubner, Martin, MD ; Minarik, Thomas, PhD ; Sevin, Emmanuel, MD ; de Gregorio, Nikolaus, MD ; Bidziński, Mariusz, Prof ; Pfisterer, Jacobus, Prof ; Malander, Susanne, MD ; Hilpert, Felix, Prof ; Mirza, Mansoor R, MD ; Scambia, Giovanni, Prof ; Meier, Werner, Prof ; Nicoletto, Maria O, MD ; Bjørge, Line, Prof ; Lortholary, Alain, MD ; Sailer, Martin Oliver, PhD ; Merger, Michael, MD ; Harter, Philipp, MD

The lancet oncology, 2016, Vol.17 (1), p.78-89 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Amengual, Jennifer E. ; Lichtenstein, Renee ; Lue, Jennifer ; Sawas, Ahmed ; Deng, Changchun ; Lichtenstein, Emily ; Khan, Karen ; Atkins, Laine ; Rada, Aishling ; Kim, Hye A. ; Chiuzan, Codruta ; Kalac, Matko ; Marchi, Enrica ; Falchi, Lorenzo ; Francescone, Mark A. ; Schwartz, Lawrence ; Cremers, Serge ; O'Connor, Owen A.

Blood, 2018-01, Vol.131 (4), p.397-407 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Fucoidan and cancer: a multifunctional molecule with anti-tumor potential
Fucoidan and cancer: a multifunctional molecule with anti-tumor potential
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fucoidan and cancer: a multifunctional molecule with anti-tumor potential

Atashrazm, Farzaneh ; Lowenthal, Ray M ; Woods, Gregory M ; Holloway, Adele F ; Dickinson, Joanne L

Marine Drugs, 2015-04, Vol.13 (4), p.2327-2346 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
8
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

POPLIN, Elizabeth ; YANG FENG ; CELLA, David ; BENSON, Al Bowen ; BERLIN, Jordan ; ROTHENBERG, Mace L ; HOCHSTER, Howard ; MITCHELL, Edith ; ALBERTS, Steven ; O'DWYER, Peter ; HALLER, Daniel ; CATALANO, Paul

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3778-3785 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
DNA binders in clinical trials and chemotherapy
DNA binders in clinical trials and chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

DNA binders in clinical trials and chemotherapy

Ali, Asfa ; Bhattacharya, Santanu

Bioorganic & medicinal chemistry, 2014-08, Vol.22 (16), p.4506-4521 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma
Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma

Barnard, Rebecca A ; Wittenburg, Luke A ; Amaravadi, Ravi K ; Gustafson, Daniel L ; Thorburn, Andrew ; Thamm, Douglas H

Autophagy, 2014-08, Vol.10 (8), p.1415-1425 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (78.637)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (84.012)
  2. magazinearticle  (81)
  3. Anais de Congresso  (69)
  4. Book Chapters  (2)
  5. Resenhas  (1)
  6. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1985  (784)
  2. 1985Até1994  (8.522)
  3. 1995Até2004  (17.574)
  4. 2005Até2015  (36.879)
  5. Após 2015  (20.407)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (80.892)
  2. Japonês  (9.144)
  3. Alemão  (1.011)
  4. Francês  (905)
  5. Espanhol  (320)
  6. Chinês  (282)
  7. Russo  (235)
  8. Italiano  (175)
  9. Holandês  (105)
  10. Português  (79)
  11. Polonês  (42)
  12. Norueguês  (39)
  13. Tcheco  (30)
  14. Húngaro  (29)
  15. Dinamarquês  (27)
  16. Hebraico  (22)
  17. Coreano  (19)
  18. Serbian  (10)
  19. Romeno  (9)
  20. Sueco  (5)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.